Photo by karsten116 from unsplash
We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically… Click to show full abstract
We compared the Sanger sequencing and the commercial INNO-LiPA® HBV assay for the routine detection of precore (PC) and basal core promoter (BCP) mutations of hepatitis B virus in chronically infected patients. The overall agreement rate between assays was 94.2% and 98.8% for the detection of PC and BCP mutations, respectively.
Keywords:
detection;
lipa hbv;
assay routine;
inno lipa;
routine detection;
sanger sequencing
Journal Title: Diagnostic microbiology and infectious disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diagnostic microbiology and infectious disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!